Zecotek Signs LFS Scintillation Crystal Supply Agreement Worth $21 million Over the Next 3 Years Jan 26, 2017
DelMar Pharmaceuticals and MD Anderson Initiate New Phase Two Clinical Trial of VAL-083 for MGMT-unmethylated Recurrent Glioblastoma Multiforme (GBM) Jan 26, 2017
Miranda Signs Letters Of Intent on Two Large District-Scale Epithermal Systems in Colombia Jan 21, 2017
Luminor Medical Announces Appointment of Daniel Cloutier to its Board of Directors and Grant of Stock Options Jan 21, 2017
Southern Silver Intersects 14.8m Grading 39.4g/t Ag, 0.1% Pb, and 10.2% Zn (410g/t AgEq; 11.6% ZnEq) at Cerro Las Minitas; Second Drill Mobilized to Property Jan 20, 2017
RedHill Biopharma Announces QIDP Fast-Track Designation Granted by FDA to RHB-104 for Nontuberculous Mycobacteria Infections Jan 12, 2017
RedHill Biopharma Announces First Dosing in RHB-105 Supportive PK Studies Ahead of Confirmatory Phase III Study for H. pylori Infection Jan 11, 2017
DelMar Pharmaceuticals Receives Additional Non-Dilutive Funding from the Government of Canada to Support Expanded Research with Lead Product Candidate VAL-083 Jan 10, 2017
RedHill Biopharma Announces Exercise of Stock Options by Directors and Senior Management Jan 10, 2017